• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Optimised design of siRNA based on multi-featured comparison and analysis of H1N1 virus

tetano

Editor, Senior Moderator
Int J Data Min Bioinform. 2013;7(4):345-57.
Optimised design of siRNA based on multi-featured comparison and analysis of H1N1 virus.
Liu Y, Chang Y, Xu D, Li Z, Zhang H, Li J, Tian M.
Source

School of Computer Science and Technology, Jilin University, Changchun 130012, China. liuyn@jlu.edu.cn
Abstract

A promising method for flu treatment is small interfering RNAs (siRNAs) designed against conserved sequences in influenza virus. In this study, we developed a computational method for designing therapeutics siRNA and applied in the recent HIN1 influenza virus based on its biological characteristics that are substantially different from seasonal influenza virus. We first compared the PA fragments between the H IN1 virus in 2009 and the seasonal influenza virus genes in 2008, and the comparison found significant differences between them not only in sequence features but also in RNA secondary structures. In particular, the RNA secondary structures only share 76.8% identity, which suggests major changes in biological characteristics. Furthermore, we designed a metric of 'structure coefficient' to measure the effectiveness of siRNA based on the secondary structure of its target. Our study provides an improved approach for siRNA design and it may help developing siRNA-based therapeutics for seasonal epidemics and reoccurring pandemics of flu.

PMID:
23798221
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23798221
 
Back
Top Bottom